跳至主要内容
临床试验/TCTR20240725003
TCTR20240725003尚未招募2 期

Adjuvant chemotherapy plus radiation versus chemotherapy alone in stage III-IVA endometrial cancer: a phase II randomized controlled trial

Mahidol University0 个研究点目标入组 75 人开始时间: 2024年7月25日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
Female

入选标准

  • 1. Participants must be 18 years of age or older.
  • 2. Participants must have been diagnosed with stage III-IVA endometrial cancer through surgical staging at Siriraj Hospital.
  • 3. Participants must not have any suspicious pathological lymph nodes on radiographic imaging (CT scan, MRI, or PET scan) following chemotherapy.

排除标准

  • 1. Participants who have progression of disease of during or after receiving chemotherapy.
  • 2. Participants who develop secondary cancer while participating in the research study.
  • 3. Participants who have previously received radiation therapy to the pelvic area.

研究者

相似试验